Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 511

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Antihypertensive peptides: Production, bioavailability and incorporation into foods

Open access
Hernández-Ledesma, Blanca, del Mar Contreras, María, Recio, Isidra·2011·Advances in Colloid and Interface Science
DOI 10.1016/j.cis.2010.11.001
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cis.2010.11.001

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 10 references

Research works printed but not linked: 206

  1. Diplock, 1999, Scientific concepts of functional foods in Europe: consensus document, Br J Nutr, 81, 51
  2. Lopez-Fandino, 2006, Physiological, chemical and technological aspects of milk-protein-derived peptides with antihypertensive and ACE-inhibitory activity, Int Dairy J, 16, 1277, 10.1016/j.idairyj.2006.06.004 · DOI · Paper page
  3. Kearney, 2005, Global burden of hypertension, Lancet, 365, 217, 10.1016/S0140-6736(05)70151-3 · DOI · Paper page
  4. Fitzgerald, 2004, Hypotensive peptides from milk proteins, J Nutr, 134, 980S, 10.1093/jn/134.4.980S · DOI · Paper page
  5. Saito, 2008, Antihypertensive peptides derived from bovine casein and whey proteins: bioactive components of milk, Adv Exp Med, 606, 295, 10.1007/978-0-387-74087-4_12 · DOI
  6. Muguruma, 2009, Identification of pro-drug type ACE inhibitory peptide sourced from porcine myosin B: evaluation of its antihypertensive effects in vivo, Food Chem, 114, 516, 10.1016/j.foodchem.2008.09.081 · DOI
  7. Miguel, 2006, Effect of simulated gastrointestinal digestion on the antihypertensive properties of ACE-inhibitory peptides derived from ovalbumin, J Agric Food Chem, 54, 726, 10.1021/jf051101p · DOI
  8. Yu, 2006, Isolation and characterization of angiotensin I-converting enzyme inhibitory peptides derived from porcine hemoglobin, Peptides, 11, 2950, 10.1016/j.peptides.2006.05.025 · DOI
  9. Jung, 2006, Angiotensin I-converting enzyme inhibitory peptide from yellowfin sole (Limanda aspera) frame protein and its antihypertensive effect in spontaneously hypertensive rats, Food Chem, 94, 26, 10.1016/j.foodchem.2004.09.048 · DOI · Paper page
  10. Qian, 2007, Antihypertensive effect of angiotensin I converting enzyme-inhibitory peptide from hydrolyzates of bigeye tuna dark muscle, Thumus obesus, J Agric Food Chem, 55, 8398, 10.1021/jf0710635 · DOI
  11. Aluko, 2008, Determination of nutritional and bioactive properties of peptides in enzymatic pea, chickpea, and mung bean protein hydrolysates, J AOAC Int, 91, 947, 10.1093/jaoac/91.4.947 · DOI
  12. Suetsuna, 1998, Isolation and characterization of angiotensin I-converting enzyme inhibitor dipeptides derived from Allium sativum L (garlic), J Nutr Biochem, 9, 415, 10.1016/S0955-2863(98)00036-9 · DOI
  13. Li, 2007, Antihypertensive effect of rice protein hydrolysate with in vitro angiotensin I-converting enzyme inhibitory activity in spontaneously hypertensive rats, Asia Pac J Clin Nutr, 16, 275
  14. Chiang, 2006, Angiotensin I-converting enzyme inhibitor derived from soy protein hydrolysates and produced by using membrane reactor, Food Chem, 98, 725, 10.1016/j.foodchem.2005.06.038 · DOI
  15. Rho, 2009, Purification and identification of an angiotensin I-converting enzyme inhibitory peptide from fermented soybean extract, Process Biochem, 44, 490, 10.1016/j.procbio.2008.12.017 · DOI
  16. Motoi, 2003, Isolation and characterization of angiotensin I-converting enzyme inhibitory peptides from wheat gliadin hydrolysate, Nahrung Food, 47, 354, 10.1002/food.200390081 · DOI
  17. Tovar-Perez, 2009, Angiotensin I-converting enzyme-inhibitory peptide fractions from albumin 1 and globulin as obtained of amaranth grain, Food Chem, 437, 10.1016/j.foodchem.2009.02.062 · DOI
  18. Davies, 1998, Research note: the effect of pH on the stability of nisin solution during autoclaving, Lett Appl Microbiol, 27, 186, 10.1046/j.1472-765X.1998.t01-1-00401.x · doi:10.1046/j.1472-765x.1998.t01-1-00401.x
  19. He, 2008, Pilot and plant scaled production of ACE inhibitory hydrolysates from Acetes chinensis and its in vivo antihypertensive effect, Bioresour Technol, 99, 5956, 10.1016/j.biortech.2007.10.038 · doi:10.1016/j.biortech.2007.10.038
  20. Bueno-Solano, 2009, Chemical and biological characteristics of protein hydrolysates from fermented shrimp by-products, Food Chem, 112, 671, 10.1016/j.foodchem.2008.06.029 · DOI
  21. Paul, 2009, Degradation of milk-based bioactive peptides by yogurt fermentation bacteria, Lett Appl Microbiol, 49, 345, 10.1111/j.1472-765X.2009.02676.x · DOI
  22. Paul, 2010, Hydrolytic breakdown of lactoferricin by lactic acid bacteria, J Ind Microbiol Biotechnol, 37, 173, 10.1007/s10295-009-0660-6 · DOI
  23. Favaro-Trindade, 2010, The use of spray drying technology to reduce bitter taste of casein hydrolysate, Food Hydrocolloids, 24, 336, 10.1016/j.foodhyd.2009.10.012 · DOI · Paper page
  24. De Vos, 2010, Encapsulation for preservation of functionality and targeted delivery of bioactive food components, Int Dairy J, 20, 292, 10.1016/j.idairyj.2009.11.008 · DOI · Paper page
  25. Maeno, 1996, Identification of an antihypertensive peptide from casein hydrolysate produced by a proteinase from Lactobacillus helveticus CP790, J Dairy Sci, 79, 1316, 10.3168/jds.S0022-0302(96)76487-1 · DOI · Paper page
  26. Quirós, 2008, Bioavalilability of the antihypertensive peptide LHLPLP: transepithelial flux of HLPLP, Int Dairy J, 18, 279, 10.1016/j.idairyj.2007.09.006 · DOI
  27. Walsh, 2004, In vitro generation and stability of the lactokinin β-lactoglobulin fragment (142–148), J Dairy Sci, 87, 3845, 10.3168/jds.S0022-0302(04)73524-9 · DOI
  28. Phelan, 2009, Casein-derived bioactive peptides: biological effects, industrial uses, safety aspects and regulatory status, Int Dairy J, 19, 643, 10.1016/j.idairyj.2009.06.001 · DOI · Paper page
  29. Gill, 1996, Biologically active peptides and enzymatic approaches to their production, Enzyme Microb Technol, 18, 163, 10.1016/0141-0229(95)00097-6 · DOI
  30. Vermeirssen, 2004, Bioavailability of angiotensin I converting enzyme inhibitory peptides, Br J Nutr, 92, 357, 10.1079/BJN20041189 · DOI · Paper page
  31. Shimizu, 2004, Food-derived peptides and intestinal functions, Biofactors, 21, 43, 10.1002/biof.552210109 · DOI
  32. Hernandez-Ledesma, 2004, Angiotensin converting enzyme inhibitory activity in commercial fermented products. Formation of peptides under simulated gastrointestinal digestion, J Agric Food Chem, 52, 1504, 10.1021/jf034997b · DOI
  33. Hernandez-Ledesma, 2004, Release of angiotensin converting enzyme inhibitory peptides by simulated gastrointestinal digestion of infant formulas, Int Dairy J, 14, 889, 10.1016/j.idairyj.2004.02.011 · DOI
  34. Hernández-Ledesma, 2007, Identification of bioactive peptides after digestion of human milk and infant formula with pepsin and pancreatin, Int Dairy J, 17, 42, 10.1016/j.idairyj.2005.12.012 · DOI · Paper page
  35. Gomez-Ruiz, 2004, Angiotensin converting enzyme-inhibitory activity of peptides isolated from Manchego cheese. Stability under simulated gastrointestinal digestion, Int Dairy J, 14, 1075, 10.1016/j.idairyj.2004.04.007 · DOI
  36. Lignitto, 2010, Angiotensin-converting, enzyme inhibitory activity of water-soluble extracts of Asiago d'allevo cheese, Int Dairy J, 20, 11, 10.1016/j.idairyj.2009.07.001 · DOI
  37. Jang, 2007, Storage stability of the synthetic angiotensin converting enzyme (ACE) inhibitory peptides separated from beef sarcoplasmic protein extracts at different pH, temperature, and gastric digestion, Food Sci Biotechnol, 16, 572
  38. Escudero, 2010, Angiotensin I-converting enzyme inhibitory peptides generated from in vitro gastrointestinal digestion of pork meat, J Agric Food Chem, 58, 2895, 10.1021/jf904204n · DOI
  39. Cinq-Mars, 2008, Investigations into inhibitor type and mode, simulated gastrointestinal digestion, and cell transport of the angiotensin I-converting enzyme-inhibitory peptides in pacific hake (Merluccius productus) fillet hydrolysate, J Agric Food Chem, 56, 410, 10.1021/jf072277p · DOI
  40. Samaranayaka, 2010, Antioxidative and angiotensin-I-converting enzyme inhibitory potential of a pacific hake (Merluccius productus) fish protein hydrolysate subjected to simulated gastrointestinal digestion and Caco-2 cell permeation, J Agric Food Chem, 58, 1535, 10.1021/jf9033199 · DOI
  41. Vermeirssen, 2003, The impact of fermentation and in vitro digestion on the formation of angiotensin-I-converting enzyme inhibitory activity from pea and whey protein, J Dairy Sci, 86, 429, 10.3168/jds.S0022-0302(03)73621-2 · DOI
  42. Akillioglu, 2009, Effects of heat treatment and in vitro digestion on the angiotensin converting enzyme inhibitory activity of some legume species, Eur Food Res Technol, 229, 915, 10.1007/s00217-009-1133-x · DOI
  43. Jiménez-Escrig, 2010, Health-promoting activities of ultra-filtered okara protein hydrolysates released by in vitro gastrointestinal digestion: identification of active peptide from soybean lipoxygenase, Eur Food Res Technol, 230, 655, 10.1007/s00217-009-1203-0 · DOI
  44. Bertrand-Harb, 2002, Thermal modifications of structure and co-denaturation of α-lactalbumin and β-lactoglobulin induce changes of solubility and susceptibility to proteases, Nahrung Food, 46, 283, 10.1002/1521-3803(20020701)46:4<283::AID-FOOD283>3.0.CO;2-A · DOI
  45. Bonomi, 2003, Reduction of immunoreactivity of bovine β-lactoglobulin upon combined physical and proteolytic treatment, J Dairy Res, 70, 51, 10.1017/S0022029902005678 · doi:10.1017/s0022029902005678
  46. Quirós, 2007, The use of high hydrostatic pressure to promote the proteolysis and release of bioactive peptides from ovalbumin, Food Chem, 104, 1734, 10.1016/j.foodchem.2006.10.050 · DOI
  47. Majumder, 2009, Angiotensin I converting enzyme inhibitory peptides from simulated in vitro gastrointestinal digestion of cooked eggs, J Agric Food Chem, 57, 471, 10.1021/jf8028557 · DOI
  48. Juillard, 1998, Specificity of milk peptide utilization by Lactococcus lactis, Appl Environ Microbiol, 64, 1230, 10.1128/AEM.64.4.1230-1236.1998 · DOI
  49. Nakamura, 1995, Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk, J Dairy Sci, 78, 777, 10.3168/jds.S0022-0302(95)76689-9 · DOI · Paper page
  50. Nakamura, 1995, Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin I-converting enzyme, J Dairy Sci, 78, 1253, 10.3168/jds.S0022-0302(95)76745-5 · DOI · Paper page
  51. Ashar, 2004, Antihypertensive peptides purified from milks fermented with Lactobacillus delbrueckii ssp bulgaricus, Milchwissenschaft, 59, 14
  52. Korhonen, 2006, Bioactive peptides: production and functionality, Int Dairy J, 16, 945, 10.1016/j.idairyj.2005.10.012 · DOI · Paper page
  53. Fuglsang, 2002, Cardiovascular effects of fermented milk containing angiotensin-converting enzyme inhibitors evaluated in permanently catheterized, spontaneously hypertensive rats, Appl Environ Microbiol, 68, 3566, 10.1128/AEM.68.7.3566-3569.2002 · DOI
  54. Fuglsang, 2003, Lactic acid bacteria: inhibition of angiotensin converting enzyme in vitro and in vivo, Antonie Leeuwenhoek, 83, 27, 10.1023/A:1022993905778 · DOI
  55. Sipola, 2002, Effect of long-term intake of milk products on blood pressure in hypertensive rats, J Dairy Res, 69, 103, 10.1017/S002202990100526X · DOI
  56. Seppo, 2003, A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects, Am J Clin Nutr, 77, 326, 10.1093/ajcn/77.2.326 · DOI · Paper page
  57. Tuomilehto, 2004, Effect of ingesting sour milk fermented using Lactobacillus helveticus bacteria producing tripeptides on blood pressure in subjects with mild hypertension, J Hum Hypertens, 18, 795, 10.1038/sj.jhh.1001745 · DOI
  58. Hata, 1996, Placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects, Am J Clin Nutr, 64, 767, 10.1093/ajcn/64.5.767 · DOI · Paper page
  59. Masuda, 1996, Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats, J Nutr, 126, 3063, 10.1093/jn/126.12.3063 · DOI · Paper page
  60. Mizushima, 2004, Randomized controlled trial of sour milk on blood pressure in borderline hypertensive men, Am J Hypertens, 17, 701, 10.1016/j.amjhyper.2004.03.674 · DOI
  61. Aihara, 2005, Effect of powdered milk fermented with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension, J Am Coll Nutr, 24, 257, 10.1080/07315724.2005.10719473 · DOI · Paper page
  62. Jauhiainen, 2005, Effect of long-term intake of milk peptides and minerals on blood pressure and arterial function in spontaneously hypertensive rats, Milchwissenschaft, 60, 358
  63. Hirota, 2007, Casein hydrolysate containing the antihypertensive tripeptides Val-Pro-Pro and Ile-Pro-Pro improves vascular endothelial function independent of blood pressure-lowering effects: contribution of the inhibitory action of angiotensin-converting enzyme, Hypertens Res, 30, 489, 10.1291/hypres.30.489 · DOI
  64. Pihlanto, 2010, Angiotensin I converting enzyme (ACE) inhibitory activity and antihypertensive effect of fermented milk, Int Dairy J, 20, 3, 10.1016/j.idairyj.2009.07.003 · DOI
  65. Quirós, 2007, Identification of novel antihypertensive peptides in milk fermented with Enterococus faecalis, Int Dairy J, 17, 33, 10.1016/j.idairyj.2005.12.011 · DOI · Paper page
  66. Miguel, 2005, Changes in arterial blood pressure in hypertensive rats caused by long-term intake of milk fermented by Enterococcus faecalis CECT 5728, Br J Nutr, 94, 36, 10.1079/BJN20051450 · DOI
  67. Miguel, 2006, Antihypertensive effect of peptides obtained from Enterococcus faecalis-fermented milk in rats, J Dairy Sci, 89, 3352, 10.3168/jds.S0022-0302(06)72372-4 · DOI
  68. Saito, 2000, Isolation and structural analysis of antihypertensive peptides that exist naturally in Gouda cheese, J Dairy Sci, 83, 1434, 10.3168/jds.S0022-0302(00)75013-2 · DOI · Paper page
  69. Smacchi, 1998, Peptides from several Italian cheeses inhibitory to proteolytic enzymes of lactic acid bacteria, Pseudomonas fluorescens ATCC 948 and to the angiotensin I-converting enzyme, Enz Microb Technol, 22, 687, 10.1016/S0141-0229(97)00261-5 · DOI
  70. Gómez-Ruiz, 2006, Identification of ACE-inhibitory peptides in different Spanish cheeses by tandem mass spectrometry, Eur Food Res Technol, 223, 595, 10.1007/s00217-005-0238-0 · DOI
  71. Miguel, 2010, Changes in arterial blood pressure after single oral administration of milk-casein-derived peptides in spontaneously hypertensive rats, Mol Nutr Food Res, 54, 1422, 10.1002/mnfr.200900448 · DOI
  72. Butikofer, 2007, Quantification of the angiotensin-converting enzyme-inhibiting tripeptides Val-Pro-Pro and Ile-Pro-Pro in hard, semi-hard and soft cheeses, Int Dairy J, 17, 968, 10.1016/j.idairyj.2006.11.003 · DOI
  73. Butikofer, 2008, Occurrence of the angiotensin-converting enzyme-inhibiting tripeptides Val-Pro-Pro and Ile-Pro-Pro in different cheese varieties of Swiss origin, J Dairy Sci, 91, 29, 10.3168/jds.2007-0413 · DOI
  74. Meyer, 2009, Hot topic: changes in angiotensin-converting enzyme inhibition and concentrations of the tripeptides Val-Pro-Pro and Ile-Pro-Pro during ripening of different Swiss cheese varieties, J Dairy Sci, 92, 826, 10.3168/jds.2008-1531 · DOI
  75. Korhonen, 2003, Food-derived bioactive peptides—opportunities for designing future foods, Curr Pharm Des, 9, 1297, 10.2174/1381612033454892 · DOI · Paper page
  76. Shin, 2001, His-His-Leu, an angiotensin I converting enzyme inhibitory peptide derived from Korean soybean paste, exerts antihypertensive activity in vivo, J Agric Food Chem, 49, 3004, 10.1021/jf001135r · DOI
  77. Okamoto, 1995, Angiotensin I converting enzyme inhibitory activities of various fermented foods, Biosci Biotechnol Biochem, 59, 1147, 10.1271/bbb.59.1147 · DOI
  78. Nakahara, 2010, Antihypertensive effect of peptide-enriched soy sauce-like seasoning and identification of its angiotensin I-converting enzyme inhibitory substances, J Agric Food Chem, 58, 821, 10.1021/jf903261h · DOI
  79. Gibbs, 2004, Production and characterization of bioactive peptides from soy hydrolysate and soy-fermented food, Food Res Int, 37, 123, 10.1016/j.foodres.2003.09.010 · DOI · Paper page
  80. Li, 2009, Comparison of angiotensin I-converting enzyme inhibitor activities of pre-fermented Douchi (a Chinese traditional fermented soybean food) started with various cultures, Int J Food Eng, 5, 10, 10.2202/1556-3758.1661 · DOI
  81. Ibe, 2009, Antihypertensive effects of natto, a traditional Japanese fermented food, in spontaneously hypertensive rats, Food Sci Technol Res, 15, 199, 10.3136/fstr.15.199 · doi:10.3136/fstr.15.199
  82. Pihlanto-Leppala, 2000, Angiotensin I-converting enzyme inhibitory properties of whey protein digests: concentration and characterization of active peptides, J Dairy Res, 67, 53, 10.1017/S0022029999003982 · DOI · Paper page
  83. Roufik, 2006, In vitro digestibility of bioactive peptides derived from β-lactoglobulin, Int Dairy J, 16, 294, 10.1016/j.idairyj.2005.03.010 · DOI
  84. Lourenço da Costa, 2007, Effect of heat and enzymatic treatment on the antihypertensive activity of whey protein hydrolysates, Int Dairy J, 17, 632, 10.1016/j.idairyj.2006.09.003 · DOI
  85. Manso, 2004, Angiotensin I converting-enzyme-inhibitory activity of bovine, ovine, and caprine κ-casein macropeptides and their tryptic hydrolysates, J Food Prot, 66, 1686, 10.4315/0362-028X-66.9.1686 · DOI
  86. Contreras, 2009, Novel casein-derived peptides with antihypertensive activity, Int Dairy J, 19, 566, 10.1016/j.idairyj.2009.05.004 · DOI
  87. Mao, 2007, Value-added utilization of yak milk casein for the production of angiotensin-I-converting enzyme inhibitory peptides, Food Chem, 103, 1282, 10.1016/j.foodchem.2006.10.041 · DOI
  88. Mizuno, 2004, Release of short and proline-rich antihypertensive peptides from casein hydrolysate with an Aspergillus oryzae protease, J Dairy Sci, 87, 3183, 10.3168/jds.S0022-0302(04)73453-0 · DOI
  89. Chicón, 2006, Influence of high hydrostatic pressure on the proteolysis of beta-lactoglobulin A by trypsin, J Dairy Res, 73, 121, 10.1017/S0022029905001664 · doi:10.1017/s0022029905001664
  90. Chicón, 2006, Changes in chymotrypsin hydrolysis of beta-lactoglobulin A induced by high hydrostatic pressure, J Agric Food Chem, 54, 2333, 10.1021/jf051983s · DOI
  91. Hernández-Ledesma, 2006, Effect of β-lactoglobulin hydrolysis with thermolysin under denaturing temperatures on the release of bioactive peptides, J Chromatogr A, 1116, 31, 10.1016/j.chroma.2006.03.006 · DOI
  92. Hernández-Ledesma, 2002, Preparation of ovine and caprine β-lactoglobulin hydrolysates with ACE-inhibitory activity. Identification of active peptides from caprine β-lactoglobulin hydrolysed with thermolysin, Int Dairy J, 12, 805, 10.1016/S0958-6946(02)00080-8 · DOI
  93. Kadkhodaee, 2008, Ultrasonic inactivation of Bacillus alpha-amylase. I. Effect of gas content and emitting face of probe, Ultrason Sonochem, 15, 133, 10.1016/j.ultsonch.2007.02.005 · DOI
  94. Lee, 2008, Ultrasound-enhanced lipase activity in the synthesis of sugar ester using ionic liquids, Proc Biochem, 43, 1009, 10.1016/j.procbio.2008.05.001 · DOI
  95. Jia, 2010, The use of ultrasound for enzymatic preparation of ACE-inhibitory peptides from wheat germ protein, Food Chem, 119, 336, 10.1016/j.foodchem.2009.06.036 · DOI · Paper page
  96. Jeong, 2007, Expression of antihypertensive peptide, His-His-Leu, as tandem repeats in Escherichia coli, J Microbiol Biotechnol, 17, 952
  97. Liu, 2007, High-level expression of milk-derived antihypertensive peptide in Escherichia coli and its bioactivity, J Agric Food Chem, 55, 5109, 10.1021/jf0703248 · DOI
  98. Lv, 2003, Expression of milk derived antihypertensive peptide in Escherichia coli, J Dairy Sci, 86, 1927, 10.3168/jds.S0022-0302(03)73779-5 · DOI
  99. Park, 1998, High-level expression of the angiotensin-converting-enzyme inhibiting peptide, YG-1, as tandem multimers in Escherichia coli, Appl Microbiol Biotechnol, 50, 71, 10.1007/s002530051258 · doi:10.1007/s002530051258
  100. Rao, 2009, Design and expression of recombinant antihypertensive peptide multimer gene in Escherichia coli BL21, J Microbiol Biotechnol, 19, 1620, 10.4014/jmb.0905.05055 · DOI
  101. Cushman, 1971, Spectrophotometric assay and properties of the angiotensin converting enzyme of rabbit lung, Biochem Pharmacol, 20, 1637, 10.1016/0006-2952(71)90292-9 · DOI · Paper page
  102. Vermeirssen, 2002, Optimisation and validation of an angiotensin-converting enzyme inhibition assay for the screening of bioactive peptides, J Biochem Biophys Methods, 51, 75, 10.1016/S0165-022X(02)00006-4 · DOI
  103. Li, 2005, Direct spectrophotometric measurement of angiotensin I-converting enzyme inhibitory activity for screening bioactive peptides, J Pharm Biomed Anal, 37, 219, 10.1016/j.jpba.2004.11.004 · doi:10.1016/j.jpba.2004.11.004
  104. Shalaby, 2006, Performance of two commonly used angiotensin-converting enzyme inhibition assays using synthetic peptide substrates, J Dairy Res, 73, 178, 10.1017/S0022029905001639 · DOI
  105. Doig, 1993, Direct injection assay of angiotensin-converting enzyme by high-performance liquid-chromatography using a shielded hydrophobic phase column, J Chrom Biomed Appl, 613, 145, 10.1016/0378-4347(93)80208-L · doi:10.1016/0378-4347(93)80208-l
  106. Mehanna, 1999, Liquid chromatographic determination of hippuric acid for the evaluation of ethacrynic acid as angiotensin converting enzyme inhibitor, J Pharm Biomed Anal, 19, 967, 10.1016/S0731-7085(98)00122-8 · doi:10.1016/s0731-7085(98)00122-8
  107. Siemerink, 2010, Development of a fast liquid chromatography/mass spectrometry screening method for angiotensin converting enzyme (ACE) inhibitors in complex natural mixtures like snake venom, Rapid Commun Mass Spectrom, 24, 687, 10.1002/rcm.4428 · doi:10.1002/rcm.4428
  108. Carmel, 1978, An intramolecularly quenched fluorescent tripeptide as a fluorogenic substrate of angiotensin-I-converting enzyme and of bacterial dipeptidyl carboxypeptidase, Eur J Biochem, 87, 265, 10.1111/j.1432-1033.1978.tb12375.x · doi:10.1111/j.1432-1033.1978.tb12375.x
  109. Sentandreu, 2006, A rapid, simple and sensitive fluorescence method for the assay of angiotensin-I converting enzyme, Food Chem, 97, 546, 10.1016/j.foodchem.2005.06.006 · DOI
  110. Van Elswijk, 2003, Rapid detection and identification of angiotensin-converting enzyme inhibitors by on-line liquid chromatography-biochemical detection, couple to electrospray mass spectrometry, J Chromatogr A, 1020, 45, 10.1016/j.chroma.2003.08.055 · DOI
  111. Geng, 2010, A rapid assay for angiotensin-converting enzyme activity using ultra-performance liquid chromatography-mass spectrometry, Biomed Chromatogr, 24, 312, 10.1002/bmc.1291 · doi:10.1002/bmc.1291
  112. Wang, 2008, Purification and identification of an ACE inhibitory peptide from oyster proteins hydrolysate and the anti hypertensive effect of hydrolysate in spontaneously hypertensive rats, Food Chem, 111, 302, 10.1016/j.foodchem.2008.03.059 · DOI
  113. Nakano, 2006, Antihypertensive effect of angiotensin I-converting enzyme inhibitory peptides from a sesame protein hydrolysate in spontaneously hypertensive rats, Biosci Biotechnol Biochem, 70, 1118, 10.1271/bbb.70.1118 · DOI
  114. Hernández-Ledesma, 2007, Effect of simulated gastrointestinal digestion on the antihypertensive properties of synthetic beta-lactoglobulin peptide sequences, J Dairy Res, 74, 336, 10.1017/S0022029907002609 · DOI
  115. Miguel, 2007, Vascular effects, angiotensin I-converting enzyme (ACE)-inhibitory activity, and antihypertensive properties of peptides derived from egg white, J Agric Food Chem, 55, 10615, 10.1021/jf072307o · DOI
  116. Takai-Doi, 2009, Antihypertensive activities of royal jelly protein hydrolysate and its fractions in spontaneously hypertensive rats, Acta Med Okayama, 63, 57
  117. Kawasaki, 2000, Antihypertensive effect of Valyl-Tyrosine, a short chain peptides derived from sardine mucle hydrolyzate, on mild hypertensive subjects, J Hum Hypertens, 14, 519, 10.1038/sj.jhh.1001065 · DOI
  118. Fujita, 2001, Effects of an ace-inhibitory agent, katsuobushi oligopeptide, in the spontaneously hypertensive rat and in borderline and mildly hypertensive subjects, Nutr Res, 21, 1149, 10.1016/S0271-5317(01)00333-5 · DOI
  119. Matsui, 2002, Absorption of Val-Tyr with in vitro Angiotensin I-converting enzyme inhibitory activity into the circulating blood system of mild hypertensive subjects, Biol Pharm Bull, 25, 1228, 10.1248/bpb.25.1228 · DOI
  120. Mizuno, 2005, Antihypertensive effect of casein hydrolysate in a placebo-controlled study in subjects with high-normal blood pressure and mild hypertension, Br J Nutr, 94, 84, 10.1079/BJN20051422 · DOI
  121. Xu, 2008, Effect of milk tripeptides on blood pressure: a meta-analysis of randomized controlled trials, Nutrition, 28, 933, 10.1016/j.nut.2008.04.004 · DOI
  122. Pripp, 2008, Effect of peptides derived from food proteins on blood pressure: a meta-analysis of randomized controlled trials, Food Nutr Res, 52, 10.3402/fnr.v52i0.1641 · DOI
  123. Van Der Zander, 2008, Enzymatically hydrolyzed lactotripeptides do not lower blood pressure in mildly hypertensive subjects, Am J Clin Nutr, 88, 1697, 10.3945/ajcn.2008.26003 · DOI
  124. Engberink, 2008, Lactotripeptides show no effect on human blood pressure. Results from a double-blind randomized controlled trial, Hypertension, 51, 399, 10.1161/HYPERTENSIONAHA.107.098988 · DOI
  125. Boelsma, 2009, Lactotripeptides and antihypertensive effects: a critical review, Br J Nutr, 101, 776, 10.1017/S0007114508137722 · DOI
  126. Jakala, 2010, Antihypertensive peptides from milk proteins, Pharmaceuticals, 3, 251, 10.3390/ph3010251 · DOI
  127. Meisel, 1997, Biochemical properties of regulatory peptides derived from milk proteins, Biopolymers, 43, 119, 10.1002/(SICI)1097-0282(1997)43:2<119::AID-BIP4>3.0.CO;2-Y · DOI
  128. Pripp, 2004, Quantitative structure–activity relationship modelling of ACE-inhibitory peptides derived from milk proteins, Eur Food Res Technol, 219, 579, 10.1007/s00217-004-1004-4 · DOI
  129. Natesh, 2003, Crystal structure of the human angiotensin-converting enzyme-lisinopril complex, Nature, 421, 551, 10.1038/nature01370 · DOI · Paper page
  130. Ondetti, 1977, Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents, Science, 196, 441, 10.1126/science.191908 · DOI · Paper page
  131. Cheung, 1980, Binding of peptide substrates and inhibitors of angiotensin-converting enzyme: importance of the COOH-terminal dipeptide sequence, J Biol Chem, 255, 401, 10.1016/S0021-9258(19)86187-2 · DOI · Paper page
  132. Ariyoshi, 1993, Angiotensin-converting enzyme inhibitors derived from food proteins, Trends Food Sci Technol, 4, 139, 10.1016/0924-2244(93)90033-7 · DOI
  133. Fitzgerald, 2000, Milk protein derived inhibitors of angiotensin-I-converting enzyme, Br J Nutr, 84, S33, 10.1017/S0007114500002221 · DOI · Paper page
  134. Gómez-Ruiz, 2004, ACE-inhibitory activity and structural properties of peptide Asp-Lys-Ile-His-Pro [beta-CN f(47–51)]. Study of the peptide forms synthesized by different methods, J Agric Food Chem, 52, 6315, 10.1021/jf049532f · DOI
  135. Vermeirssen, 2004, A quantitative in silico analysis calculates the angiotensin I converting enzyme (ACE) inhibitory activity in pea and whey protein digests, Biochimie, 86, 231, 10.1016/j.biochi.2004.01.003 · DOI
  136. Nakamura, 1996, Decrease of tissue angiotensin I-converting enzyme activity upon feeding sour milk in spontaneously hypertensive rats, Biosci Biotechnol Biochem, 60, 488, 10.1271/bbb.60.488 · DOI
  137. Jakala, 2009, Cardiovascular activity of milk casein-derived tripeptides and plant sterols in spontaneously hypertensive rats, J Physiol Pharmacol, 60, 11
  138. Jakala, 2009, Casein-derived bioactive tripeptides Ile-Pro-Pro and Val-Pro-Pro attenuate the development of hypertension and improve endothelial function in salt-loades Goto-Kakizaki rats, J Funct Foods, 1, 366, 10.1016/j.jff.2009.09.003 · DOI
  139. Jakala, 2009, Milk protein-derived bioactive tripeptides Ile-Pro-Pro and Val-Pro-Pro protect endothelial function in vitro in hypertensive rats, J Funct Foods, 1, 266, 10.1016/j.jff.2009.03.002 · DOI
  140. Yamaguchi, 2009, Study of the mechanism of antihypertensive peptide VPP and IPP in spontaneously hypertensive rats by DNA microarray analysis, Eur J Pharmacol, 620, 71, 10.1016/j.ejphar.2009.08.005 · DOI
  141. Kuono, 2005, Effects of dried bonito (Katsuobushi) and captopril, and angiotensin I-converting enzyme inhibitor, on rat isolated aorta: a possible mechanism of antihypertensive action, Biosci Biotechnol Biochem, 69, 911, 10.1271/bbb.69.911 · DOI
  142. Maes, 2004, Influence of the lactokinin Ala-Leu-Pro-Met-His-Ile-Arg (ALPMHIR) on the release of endothelin-1 by endothelial cells, Regul Pept, 118, 105, 10.1016/j.regpep.2003.11.005 · DOI
  143. Nurminen, 2000, Alpha-lactorphin lowers blood pressure measured by radiotelemetry in normotensive and spontaneously hypertensive rats, Life Sci, 66, 153, 10.1016/S0024-3205(00)00471-9 · DOI
  144. Sipola, 2002, α-Lactorphin and β-lactorphin improve arterial function in spontaneously hypertensive rats, Life Sci, 71, 1245, 10.1016/S0024-3205(02)01793-9 · DOI
  145. Ijäs, 2004, Antihypertensive opioid-like milk peptide alpha-lactorphin: lack of effect on behavioural tests in mice, Int Dairy J, 14, 201, 10.1016/j.idairyj.2003.08.002 · DOI
  146. Yamada, 2002, Design of a highly potent anti-hypertensive peptides based on ovokinin(2–7), Biosci Biotechnol Biochem, 66, 1213, 10.1271/bbb.66.1213 · DOI
  147. Touyz, 2004, Reactive oxygen species, vascular oxidative stress and redox signalling in hypertension: what is the clinical significance?, Hypertension, 44, 248, 10.1161/01.HYP.0000138070.47616.9d · DOI · Paper page
  148. Rival, 2001, Caseins and casein hydrolyzates. 2. Antioxidant properties and relevance to lipoxygenase inhibition:, J Agric Food Chem, 49, 295, 10.1021/jf0003911 · DOI · Paper page
  149. Ohsawa, 2008, Producibility and digestibility of antihypertensive β-casein tripeptides, Val-Pro-Pro and Ile-Pro-Pro, in the gastrointestinal tract: analyses using an in vitro model of mammalian gastrointestinal digestion, J Agric Food Chem, 56, 854, 10.1021/jf072671n · DOI
  150. Foltz, 2008, The angiotensin converting enzyme inhibitory tripeptides Ile-Pro-Pro and Val-Pro-Pro show increasing permeabilities with increasing physiological relevance of absorption models, Peptides, 12, 1312, 10.1016/j.peptides.2008.03.021 · DOI
  151. Quirós, 2009, Stability to gastrointestinal enzymes and structure–activity relationship of β-casein peptides with antihypertensive properties, Peptides, 30, 1848, 10.1016/j.peptides.2009.06.031 · DOI
  152. Van Platerink, 2006, Quantification of ACE inhibiting peptides in human plasma using high performance liquid chromatography-mass spectrometry, J Chromatogr B, 830, 151, 10.1016/j.jchromb.2005.10.036 · DOI · Paper page
  153. Van der Pijl, 2008, Pharmacokinetics of proline-rich tripeptides in the pig, Peptides, 29, 2196, 10.1016/j.peptides.2008.08.011 · DOI
  154. Foltz, 2007, Angiotensin converting enzyme inhibitory peptides from a lactotripeptide-enriched milk beverage are absorbed intact into the circulation, J Nutr, 137, 953, 10.1093/jn/137.4.953 · DOI · Paper page
  155. Saha, 2001, Debittering of protein hydrolysates, Biotechnol Adv, 19, 355, 10.1016/S0734-9750(01)00070-2 · DOI
  156. FitzGerald, 2006, Enzymatic debittering of food protein hydrolysates, Biotechnol Adv, 24, 234, 10.1016/j.biotechadv.2005.11.002 · DOI
  157. Wu, 2007, Quantitative structure–activity relationship study of bitter di-and tri-peptides including relationship with angiotensin I-converting enzyme inhibitory activity, J Pept Sci, 13, 63, 10.1002/psc.800 · DOI
  158. Matsuura, 1980, Bitter-masking effect of glutamylglutamic acid isomers, Seikatsu Kagaku, 12, 199
  159. Tamura, 1990, Studies on flavoured peptides. 7. Practical debittering using model peptides and related-compounds:, Agric Biol Chem, 54, 41, 10.1271/bbb1961.54.41 · DOI
  160. Molina Ortiz, 2009, Production and properties of casein hydrolysate microencapsulated by spray drying with soybean protein isolate, LWT Food Sci Technol, 42, 919, 10.1016/j.lwt.2008.12.004 · DOI
  161. Rocha, 2009, Microcapsules of a casein hydrolysate: production, characterization, and application in protein bars, Food Sci Technol Int, 15, 407, 10.1177/1082013209346042 · doi:10.1177/1082013209346042
  162. Barbosa, 2004, Papain hydrolysates of casein: molecular weight profile and encapsulation in lipospheres, J Sci Food Agric, 84, 1891, 10.1002/jsfa.1855 · doi:10.1002/jsfa.1855
  163. Gharsallaoui, 2007, Applications of spray-drying in microencapsulation of food ingredients: an overview, Food Res Int, 40, 1107, 10.1016/j.foodres.2007.07.004 · DOI · Paper page
  164. Ogasawara, 2006, Taste properties of Maillard-reaction products prepared from 1000 to 5000Da peptide, Food Chem, 99, 600, 10.1016/j.foodchem.2005.08.040 · DOI
  165. Van Boeckel, 1993, Antimutagenic effects of casein and its digestion products, Food Chem Toxicol, 31, 731, 10.1016/0278-6915(93)90144-N · DOI
  166. Elias, 2008, Antioxidant activity of proteins and peptides, Crit Rev Food Sci Nutr, 48, 430, 10.1080/10408390701425615 · DOI · Paper page
  167. Jang, 2007, Storage stability of the synthetic angiotensin converting enzyme (ACE) inhibitory peptides separated from beef sarcoplasmic protein extracts at different pH, temperature, and gastric digestion, Food Sci Biotechnol, 16, 572
  168. Reunanen, 2004, Bioassay for nisin in sausage; a shelf life study of nisin in cooked sausage, Meat Sci, 66, 515, 10.1016/S0309-1740(03)00137-2 · DOI
  169. Contreras MM, Monroy-Ruiz J, Sevilla MA, Amigo L, Gómez-Sala B, Ramos M., Recio I. Food-grade production of an antihypertensive casein hydrolysate and resistance of active peptides to drying and storage: Int Dairy J (in press). · DOI
  170. Zhong, 2009, Sustained release of lysozyme from zein microcapsules produced by a supercritical anti-solvent process, Food Chem, 115, 697, 10.1016/j.foodchem.2008.12.063 · doi:10.1016/j.foodchem.2008.12.063
  171. Hwang, 2010, The feasibility of antihypertensive oligopeptides encapsulated in liposomes prepared with phytosterols-β-sitosterol or stigmasterol, Food Res Int, 43, 133, 10.1016/j.foodres.2009.09.007 · DOI
  172. Doucet, 2001, Rheological characterization of a gel formed during extensive enzymatic hydrolysis, J Food Sci, 66, 711, 10.1111/j.1365-2621.2001.tb04626.x · doi:10.1111/j.1365-2621.2001.tb04626.x
  173. Otte, 2000, Identification of peptides in aggregates formed during hydrolysis of β-lactoglobulin B with a Glu and Asp specific microbial protease, J Agric Food Chem, 48, 2443, 10.1021/jf990947o · doi:10.1021/jf990947o
  174. Kosters, 2010, SELDI-TOF-MS as a rapid tool to study food related protein-peptide interactions, Food Hydrocolloids, 24, 667, 10.1016/j.foodhyd.2010.03.011 · DOI
  175. Noiseux, 2002, Interactions between bovine β-lactoglobulin and peptides under different physicochemical conditions, J Agric Food Chem, 50, 1587, 10.1021/jf010887y · DOI
  176. Roufik, 2006, Thermodynamics of binding interactions between bovine β-lactoglobulin A and the antihypertensive peptide β-Lg f142-148, Biomacromolecules, 7, 419, 10.1021/bm050229c · DOI
  177. Roufik, 2006, Interactions between bovine β-lactoglobulin A and various bioactive peptides as studied by front-face fluorescence spectroscopy, J Agric Food Chem, 54, 4962, 10.1021/jf060506m · DOI
  178. Meltretter, 2008, Application of mass spectrometry for the detection of glycation and oxidation products in milk proteins, Ann NY Acad Sci, 1126, 134, 10.1196/annals.1433.022 · DOI
  179. Morgan, 1998, Lactolation of [beta]-lactoglobulin monitored by electrospray ionisation mass spectrometry, Int Dairy J, 8, 95, 10.1016/S0958-6946(98)00025-9 · doi:10.1016/s0958-6946(98)00025-9
  180. Walstra, 1993, Principles of emulsion formation, Chem Eng Sci, 48, 333, 10.1016/0009-2509(93)80021-H · DOI · Paper page
  181. Van der Ven, 2001, Emulsion properties of casein and whey protein hydrolysates and the relation with other hydrolysate characteristics, J Agric Food Chem, 49, 5005, 10.1021/jf010144c · DOI
  182. Ramchandran, 2008, Effect of addition of Versagel on microbial, chemical, and physical properties of low-fat yogurt, J Food Sci, 73, M360, 10.1111/j.1750-3841.2008.00888.x · DOI
  183. Ramchandran, 2009, Effect of exopolysaccharides on the proteolytic and angiotensin-I converting enzyme-inhibitory activities and textural and rheological properties of low-fat yogurt during refrigerated storage, J Dairy Sci, 92, 895, 10.3168/jds.2008-1796 · DOI
  184. Mestdagh, 2005, Protective influence of several packaging materials on light-oxidation of milk, J Dairy Sci, 88, 499, 10.3168/jds.S0022-0302(05)72712-0 · doi:10.3168/jds.s0022-0302(05)72712-0
  185. Sinha, 2007, Whey protein hydrolysate: functional properties, nutritional quality and utilization in beverage formulation, Food Chem, 101, 1484, 10.1016/j.foodchem.2006.04.021 · DOI
  186. Maeno, 2005, Int J Toxicol, 24, 13, 10.1080/10915810500259556 · DOI
  187. Mizuno, 2005, Studies of the toxicological potential of tripeptides (L-valyl-L-prolyl-L-proline and L-isoleucyl-L-prolyl-L-proline): V. A 13-week toxicity study of tripeptides-containing casein hydrolysate in male and female rats, Int J Toxicol, 24, 41, 10.1080/10915810500259606 · doi:10.1080/10915810500259606
  188. Kurosaki, 2005, Studies of the toxicological potential of tripeptides (L-valyl-L-prolyl-L-proline and L-isoleucyl-L-prolyl-L-proline): VI. Effects of Lactobacillus helveticus-fermented milk powder on fertility and reproductive performance of rats, Int J Toxicol, 24, 61, 10.1080/10915810500259630 · doi:10.1080/10915810500259630
  189. Gómez-Ruiz, 2002, Angiotensin-converting enzyme-inhibitory peptides in Manchego cheeses manufactured with different starter cultures, Int Dairy J, 12, 697, 10.1016/S0958-6946(02)00059-6 · DOI
  190. Quirós, 2005, Angiotensin-converting enzyme inhibitory activity of peptides derived from caprine kefir, J Dairy Sci, 88, 3480, 10.3168/jds.S0022-0302(05)73032-0 · DOI · Paper page
  191. Karaki, 1990, Antihypertensive effect of tryptic hydrolysate of milk casein in spontaneously hypertensive rats, Comp Biochem Physiol C Pharmacol Toxicol Endocrinol, 96, 367, 10.1016/0742-8413(90)90023-3 · DOI
  192. Abubakar, 1998, Structural analysis of new antihypertensive peptides derived from cheese whey protein by proteinase K digestion, J Dairy Sci, 81, 3131, 10.3168/jds.S0022-0302(98)75878-3 · DOI · Paper page
  193. Gómez-Ruiz, 2007, Identification of novel angiotensin converting enzyme-inhibitory peptides from ovine milk proteins by CE-MS and chromatographic techniques, Electrophoresis, 28, 4202, 10.1002/elps.200700324 · DOI
  194. Miguel, 2007, Vascular effects and antihypertensive properties of kappa-casein macropeptide, Int Dairy J, 17, 1473, 10.1016/j.idairyj.2007.04.009 · DOI
  195. Murakami, 2004, Structural analysis of a new anti-hypertensive peptide (β-Lactosin B) isolated from a commercial whey product, J Dairy Sci, 87, 1967, 10.3168/jds.S0022-0302(04)70013-2 · DOI
  196. Korhonen, 2009, Milk-derived bioactive peptides: From science to applications, J Funct Foods, 1, 177, 10.1016/j.jff.2009.01.007 · DOI · Paper page
  197. Sano, 2005, Effect of casein hydrolysate, prepared with protease derived from Aspergillus oryzae, on subjects with high-normal blood pressure or mild hypertension, J Med Food, 8, 423, 10.1089/jmf.2005.8.423 · DOI
  198. Seppo, 2002, The effect of a Lactobacillus helveticus LBK-16H fermented milk on hypertension—a pilot study on humans, Milchwissenschaft, 57, 124
  199. Jauhiainen, 2007, Lactobacillus helveticus fermented milk reduces arterial stiffness in hypertensive subjects, Int Dairy J, 17, 1209, 10.1016/j.idairyj.2007.03.002 · DOI
  200. Jauhiainen, 2010, Long-term intervention with Lactobacillus helveticus fermented milk reduces augmentation index in hypertensive subjects, Eur J Clin Nutr, 64, 424, 10.1038/ejcn.2010.3 · DOI

200 of 206 shown

Cited by

See all 511

Metadata

Authors
Hernández-Ledesma, B., del Mar Contreras, M., & Recio, I.
Venue
Advances in Colloid and Interface Science
Publisher
Elsevier BV
Published
2011-06
Volume
165
Issue
1
Pages
23-35
ISSN
0001-8686 (ISSN-L)
DOI
10.1016/j.cis.2010.11.001
OpenAlex
W2164472370
Cited by
511
References
10
FWCI
8.51
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antihypertensive peptides: Production, bioavailability and incorporation into foods. https://app.cochat.ai/papers/10.1016/j.cis.2010.11.001
The paper
Hernández-Ledesma, B., del Mar Contreras, M., & Recio, I. (2011). Antihypertensive peptides: Production, bioavailability and incorporation into foods. Advances in Colloid and Interface Science. https://doi.org/10.1016/j.cis.2010.11.001

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.